COVID-19 induced ARDS: immunopathology and therapeutics
The coronavirus disease-2019 (COVID-19) pandemic is a significant threat in the modern era. Clinical studies show that the most common symptom of severe COVID-19 is viral pneumonia-induced acute respiratory distress syndrome (ARDS). The underlying mechanisms by which severe respiratory disease syndr...
Main Authors: | Sneha Das, Tamanna Sharma, Asha Bhardwaj, Rupesh K. Srivastava |
---|---|
Format: | Article |
Language: | English |
Published: |
Open Exploration Publishing Inc.
2023-08-01
|
Series: | Exploration of Immunology |
Subjects: | |
Online Access: | https://www.explorationpub.com/Journals/ei/Article/1003101 |
Similar Items
-
A 21st Century Evil: Immunopathology and New Therapies of COVID-19
by: Taylon Felipe Silva, et al.
Published: (2020-10-01) -
Immunopathogenesis of severe acute respiratory syndrome coronavirus-2: evolving knowledge and its current status
by: Nitin Saksena, et al.
Published: (2021-06-01) -
Continuous prolonged prone positioning in COVID-19-related ARDS: a multicenter cohort study from Chile
by: Rodrigo A. Cornejo, et al.
Published: (2022-11-01) -
Alveolar cytokines and interferon autoantibodies in COVID-19 ARDS
by: Trine B. Jonassen, et al.
Published: (2024-03-01) -
Signaling pathways and potential therapeutic targets in acute respiratory distress syndrome (ARDS)
by: Qianrui Huang, et al.
Published: (2024-01-01)